Shacey Petrovic

Shacey Petrovic has served on Insulet Corporation’s board of directors since September 2018. She has also served as an advisor to Insulet since June 2022. Ms. Petrovic has held various executive positions at Insulet, including from January 2019 to May 2022, President and Chief Executive Officer; from October 2016 to December 2018, President and Chief Operating Officer; from February 2016 to October 2016, Executive Vice President and President, Diabetes Products; and from February 2015 to February 2016, Chief Commercial Officer. From 2013 to 2015, Ms. Petrovic served as President and Chief Executive Officer of Clinical Innovations, LLC, a developer and manufacturer of medical devices and diagnostics for women’s health. From 2000 to 2013, she served in a number of key roles at Hologic, Inc. and Cytyc Corporation, which merged with Hologic in October 2007, including Vice President and General Manager of Hologic’s GYN Surgical Products division, as well as various sales and marketing leadership roles in the U.S. and Europe. Ms. Petrovic earned her Bachelor of Science in Biology from the University of Wisconsin. She also currently serves on the Board of Directors for Ambu A/S. Ms. Petrovic’s significant executive and board experience and her decades of experience within the healthcare industry provides a valuable perspective to the Board of Directors.